Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Clinical outcomes from the CDC's Colorectal Cancer Screening Demonstration Program.

Seeff LC, Royalty J, Helsel WE, Kammerer WG, Boehm JE, Dwyer DM, Howe WR Jr, Joseph D, Lane DS, Laughlin M, Leypoldt M, Marroulis SC, Mattingly CA, Nadel MR, Phillips-Angeles E, Rockwell TJ, Ryerson AB, Tangka FK.

Cancer. 2013 Aug 1;119 Suppl 15:2820-33. doi: 10.1002/cncr.28163.

2.

Risk factors for the development of placebo adverse reactions in a multicenter clinical trial.

Tangrea JA, Adrianza ME, Helsel WE.

Ann Epidemiol. 1994 Jul;4(4):327-31.

PMID:
7921323
3.

Clinical and laboratory adverse effects associated with long-term, low-dose isotretinoin: incidence and risk factors. The Isotretinoin-Basal Cell Carcinomas Study Group.

Tangrea JA, Adrianza E, Helsel WE, Taylor PR, Hartman AM, Peck GL, Edwards BK.

Cancer Epidemiol Biomarkers Prev. 1993 Jul-Aug;2(4):375-80.

4.

Isotretinoin and the axial skeleton.

Tangrea JA, Taylor PR, Hartman AM, Edwards BK, Kilcoyne RF, Helsel WE, Adrianza ME, Peck GL.

Lancet. 1992 Aug 22;340(8817):495-6. No abstract available.

PMID:
1354829
5.

Skeletal hyperostosis in patients receiving chronic, very-low-dose isotretinoin.

Tangrea JA, Kilcoyne RF, Taylor PR, Helsel WE, Adrianza ME, Hartman AM, Edwards BK, Peck GL.

Arch Dermatol. 1992 Jul;128(7):921-5.

PMID:
1626958
6.

Patients' perceptions on participation in a cancer chemoprevention trial.

Tangrea JA, Adrianza ME, Helsel WE.

Cancer Epidemiol Biomarkers Prev. 1992 May-Jun;1(3):325-30. No abstract available.

PMID:
11656233
7.

Patients' perceptions on participation in a cancer chemoprevention trial.

Tangrea JA, Adrianza ME, Helsel WE.

Cancer Epidemiol Biomarkers Prev. 1992 May-Jun;1(4):325-30.

8.

Physical activity and risk of large bowel cancer in the Framingham Study.

Ballard-Barbash R, Schatzkin A, Albanes D, Schiffman MH, Kreger BE, Kannel WB, Anderson KM, Helsel WE.

Cancer Res. 1990 Jun 15;50(12):3610-3.

9.

Body fat distribution and breast cancer in the Framingham Study.

Ballard-Barbash R, Schatzkin A, Carter CL, Kannel WB, Kreger BE, D'Agostino RB, Splansky GL, Anderson KM, Helsel WE.

J Natl Cancer Inst. 1990 Feb 21;82(4):286-90.

PMID:
2299677
10.

Is alcohol consumption related to breast cancer? Results from the Framingham Heart Study.

Schatzkin A, Carter CL, Green SB, Kreger BE, Splansky GL, Anderson KM, Helsel WE, Kannel WB.

J Natl Cancer Inst. 1989 Jan 4;81(1):31-5.

PMID:
2908919
11.
12.

Macrophage production of fibronectin, a chemoattractant for fibroblasts.

Tsukamoto Y, Helsel WE, Wahl SM.

J Immunol. 1981 Aug;127(2):673-8.

PMID:
6166682

Supplemental Content

Loading ...
Support Center